Capmatinib Terminated Phase 1 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Squamous Cell Carcinoma of Head and Neck (SCCHN) / Metastatic Colorectal Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02205398Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy